Shayan Essapoor, | |
2637 Shadelands Dr, Walnut Creek, CA 94598-2512 | |
(925) 464-1982 | |
(925) 464-2042 |
Full Name | Shayan Essapoor |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 6 Years |
Location | 2637 Shadelands Dr, Walnut Creek, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083103725 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | E5717 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bass Medical Group | 9032111281 | 309 |
News Archive
A new study has shown that people who live in cold and dark regions tend to be heavy drinkers. The data comes from participants of around 193 countries and shows that there is a connection between weather, alcohol consumption as well as alcohol associated liver disease.
Even in food-abundant industrialized countries like the U.S., an alarming number of people, particularly seniors, are in a state of diseased-associated malnutrition. Because of the impact on patient health, disease-associated malnutrition imposes a significant economic burden on society of $157 billion per year, according to new research published in a supplemental issue of the Journal of Parenteral and Enteral Nutrition and supported by Abbott.
University of Rochester researchers, who have been investigating new therapies for hot flashes for several years, report in the July Obstetrics and Gynecology journal that the seizure drug gabapentin is as effective as estrogen
Aquila-Histoplex, a contract research organisation specialised in histological and multiplex staining technologies, was today announced as the first accredited RNAscope® Certified Service Provider in Europe by Advanced Cell Diagnostics, Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
› Verified 4 days ago
Provider Name | Bass Medical Group |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1174253405 PECOS PAC ID: 9032111281 Enrollment ID: O20070201000181 |
News Archive
A new study has shown that people who live in cold and dark regions tend to be heavy drinkers. The data comes from participants of around 193 countries and shows that there is a connection between weather, alcohol consumption as well as alcohol associated liver disease.
Even in food-abundant industrialized countries like the U.S., an alarming number of people, particularly seniors, are in a state of diseased-associated malnutrition. Because of the impact on patient health, disease-associated malnutrition imposes a significant economic burden on society of $157 billion per year, according to new research published in a supplemental issue of the Journal of Parenteral and Enteral Nutrition and supported by Abbott.
University of Rochester researchers, who have been investigating new therapies for hot flashes for several years, report in the July Obstetrics and Gynecology journal that the seizure drug gabapentin is as effective as estrogen
Aquila-Histoplex, a contract research organisation specialised in histological and multiplex staining technologies, was today announced as the first accredited RNAscope® Certified Service Provider in Europe by Advanced Cell Diagnostics, Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Shayan Essapoor, 2637 Shadelands Dr, Walnut Creek, CA 94598-2512 Ph: (925) 464-1982 | Shayan Essapoor, 2637 Shadelands Dr, Walnut Creek, CA 94598-2512 Ph: (925) 464-1982 |
News Archive
A new study has shown that people who live in cold and dark regions tend to be heavy drinkers. The data comes from participants of around 193 countries and shows that there is a connection between weather, alcohol consumption as well as alcohol associated liver disease.
Even in food-abundant industrialized countries like the U.S., an alarming number of people, particularly seniors, are in a state of diseased-associated malnutrition. Because of the impact on patient health, disease-associated malnutrition imposes a significant economic burden on society of $157 billion per year, according to new research published in a supplemental issue of the Journal of Parenteral and Enteral Nutrition and supported by Abbott.
University of Rochester researchers, who have been investigating new therapies for hot flashes for several years, report in the July Obstetrics and Gynecology journal that the seizure drug gabapentin is as effective as estrogen
Aquila-Histoplex, a contract research organisation specialised in histological and multiplex staining technologies, was today announced as the first accredited RNAscope® Certified Service Provider in Europe by Advanced Cell Diagnostics, Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
› Verified 4 days ago
Dr. Jennifer Kim, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4000 | |
Cheryl J. Hanson, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4000 | |
Joseph Raymond Bartis, OPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3300 Tice Creek Dr #8, Walnut Creek, CA 94595 Phone: 925-210-0123 | |
Dr. Ali Khavari, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2637 Shadelands Dr Ste H, Walnut Creek, CA 94598 Phone: 925-464-1982 | |
Eman Elmi, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2637 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-464-1982 Fax: 925-464-2042 | |
Cecile Shepard Adobe Foot Clinic Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 106 La Casa Via Ste 270, Walnut Creek, CA 94598 Phone: 925-988-7550 Fax: 925-686-5807 |